G. Pallares

A quantitative analysis of kinase inhibitor selectivity

Mindy I. Davis, L. Wodicka, P. Zarrinkar, 2008, Nature Biotechnology.

Comprehensive analysis of kinase inhibitor selectivity

Mindy I. Davis, L. Wodicka, P. Zarrinkar, 2011, Nature Biotechnology.

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology

L. Wodicka, S. Knapp, O. Fedorov, 2014, Nature chemical biology.

AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML).

P. Zarrinkar, Mazen W. Karaman, G. Pallares, 2009, Blood.

Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment Hit.

S. Knapp, O. Fedorov, M. Bunnage, 2016, Journal of medicinal chemistry.

DETERMINATION OF GOOD MILKING PRACTICES IN A GROUP OF STOCK FARMER MANAGEMENT DEVICES OF THE CUNDIBOYACENSE HIGH ALTITUDE PLAIN

G. Pallares, A. C. Rangel, F. Castro, 2008 .

treatment of acute myeloid leukemia (AML) AC220 is a uniquely potent and selective inhibitor of FLT3 for the

P. Zarrinkar, Mazen W. Karaman, G. Pallares, 2013 .